Ali Moravej
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Moravej has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Mehdi Kalani
Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
6 shared publications - Manoochehr Rasouli
Shiraz University of Medical Sciences-Clinical Microbiology Research Center, Shiraz, Iran
3 shared publications - Simin Kiany
Shiraz University of Medical Sciences
3 shared publications Abbas Shahi
Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
1 shared publicationAbdolreza Karami
Jahrom Islamic Azad Univ, Dept Microbiol, Jahrom, Iran
1 shared publication- Ali Bidmeshkipour
Department of biology, Faculty of science, Razi University, Kermanshah, Iran
1 shared publication
Latest Publications
- 3 June 2025
- Published by Springer Nature in Inflammation Research
- Vol. 74 (1) , 1-51
The relationship between neurodevelopmental disorders (NDDs) and NLRP3 inflammasome
The brain's process of creating neural networks that affect functionality or performance is referred to as neurodevelopment. A person's capacity to learn and remember, pay attention, regulate their emotions, socialize, exercise and self-control are just a few of the cognitive and motor abilities that can be affected by abnormal brain development. Numerous neurodevelopmental diseases have been functionally related to abnormalities in innate immune signaling networks. Innate immunity is in charge of the defense of humans against pathogens and tissue damage by triggering inflammation, mainly through sensing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). Some of these inflammatory processes have been shown to be mediated by large multiprotein complexes called inflammasomes which are present in cytosol and play important roles in the immune system. Due to its role in defense against infectious agents, bacteria, viruses, and fungi, NLRP3 is almost the most studied and well-known member of inflammasomes. The involvement of NLRP3 in inflammatory illnesses is evident due to the wide range of triggers and its intricate signaling pathways. In disorders with neurodevelopmental underpinnings, such as autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), schizophrenia (SCZ), obsessive compulsive disorder (OCD), bipolar disorder (BD), Tourette syndrome (TS), etc., neuroinflammation plays a significant role in their pathophysiology. For these reasons, we reviewed the roles of NLRP3 in various neurodevelopmental disorders below.
- 3 June 2025
- Published by Springer Nature in Inflammation Research
- Vol. 74 (1) , 1-51
The relationship between neurodevelopmental disorders (NDDs) and NLRP3 inflammasome
The brain's process of creating neural networks that affect functionality or performance is referred to as neurodevelopment. A person's capacity to learn and remember, pay attention, regulate their emotions, socialize, exercise and self-control are just a few of the cognitive and motor abilities that can be affected by abnormal brain development. Numerous neurodevelopmental diseases have been functionally related to abnormalities in innate immune signaling networks. Innate immunity is in charge of the defense of humans against pathogens and tissue damage by triggering inflammation, mainly through sensing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). Some of these inflammatory processes have been shown to be mediated by large multiprotein complexes called inflammasomes which are present in cytosol and play important roles in the immune system. Due to its role in defense against infectious agents, bacteria, viruses, and fungi, NLRP3 is almost the most studied and well-known member of inflammasomes. The involvement of NLRP3 in inflammatory illnesses is evident due to the wide range of triggers and its intricate signaling pathways. In disorders with neurodevelopmental underpinnings, such as autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), schizophrenia (SCZ), obsessive compulsive disorder (OCD), bipolar disorder (BD), Tourette syndrome (TS), etc., neuroinflammation plays a significant role in their pathophysiology. For these reasons, we reviewed the roles of NLRP3 in various neurodevelopmental disorders below.
- Open Access
- 25 July 2022
- Published by MDPI AG in Preprints.org
Cancer Stem Cells and Competing Endogenous RNAs
Cancer stem cells (CSCs) are one of the cell types that account for cancer heterogeneity. They arrest in the G0 phase and generate non-CSC progeny by self-renewing and pluripotency activity, resulting in tumor recurrence, metastasis, and chemoresistance. One CSC can stimulate tumor relapse and can re-grow a metastatic tumor. So, CSC is a promising target for eradicating tumors, and developing an anti-CSC method has become a top priority in cancer therapy. In recent years competing endogenous RNA (ceRNA) have emerged as an important class of post-transcriptional regulators that affect gene expression via competition for microRNA (miRNA) binding. Furthermore, aberrant ceRNA expression is associated with tumor progression. To overcome therapeutic resistance due to CSCs, we need to improve our existing understanding of the mechanisms by which ceRNAs are implicated in CSC-related relapse. Thus, this review was designed in order to discuss the role of ceRNAs in CSCs function. We reviewed the role of ceRNAs in acquiring CSCs characteristics in the form of different pathways including Rho GTPase/F-actin_ Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ) (Hippo), Wnt/β-catenin pathway, transforming growth factor (TGF)-b–urothelial carcinoma-associated 1 (UCA1)–Slug pathway, etc. Finally, considering the comprehensive impacts of the ceRNA network on different pathways, a treatment strategy driving the ceRNA network might be effective. Targeting ceRNAs may open the path for new cancer therapeutic targets and can be used in clinical research.
- 25 July 2022
- Published by MDPI AG in Preprints.org
Open AccessCancer Stem Cells and Competing Endogenous RNAs
Cancer stem cells (CSCs) are one of the cell types that account for cancer heterogeneity. They arrest in the G0 phase and generate non-CSC progeny by self-renewing and pluripotency activity, resulting in tumor recurrence, metastasis, and chemoresistance. One CSC can stimulate tumor relapse and can re-grow a metastatic tumor. So, CSC is a promising target for eradicating tumors, and developing an anti-CSC method has become a top priority in cancer therapy. In recent years competing endogenous RNA (ceRNA) have emerged as an important class of post-transcriptional regulators that affect gene expression via competition for microRNA (miRNA) binding. Furthermore, aberrant ceRNA expression is associated with tumor progression. To overcome therapeutic resistance due to CSCs, we need to improve our existing understanding of the mechanisms by which ceRNAs are implicated in CSC-related relapse. Thus, this review was designed in order to discuss the role of ceRNAs in CSCs function. We reviewed the role of ceRNAs in acquiring CSCs characteristics in the form of different pathways including Rho GTPase/F-actin_ Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ) (Hippo), Wnt/β-catenin pathway, transforming growth factor (TGF)-b–urothelial carcinoma-associated 1 (UCA1)–Slug pathway, etc. Finally, considering the comprehensive impacts of the ceRNA network on different pathways, a treatment strategy driving the ceRNA network might be effective. Targeting ceRNAs may open the path for new cancer therapeutic targets and can be used in clinical research.
- 1 July 2021
- Published by Elsevier in Experimental Parasitology
- Vol. 226-227, 108122
Interleukine-22 gene variants are associated with susceptibility to visceral leishmaniasis
- 1 July 2021
- Published by Elsevier in Experimental Parasitology
- Vol. 226-227, 108122
Interleukine-22 gene variants are associated with susceptibility to visceral leishmaniasis
- Open Access
- 25 October 2018
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 9 (1) , 1-18
Induction of CD4+CD25+FOXP3+ regulatory T cells by mesenchymal stem cells is associated with modulation of ubiquitination factors and TSDR demethylation
Mesenchymal stem cells (MSCs) are known for their ability to induce the conversion of conventional T cells (Tconvs) into induced regulatory T cells (iTregs) in specific inflammatory contexts. Stable Foxp3 expression plays a major role in the phenotypic and functional stability of iTregs. However, how MSCs induce stable Foxp3 expression remains unknown. We first investigated the role of cell–cell contact and cytokine secretion by bone marrow-derived MSCs (BM-MSCs) on the induction, stability, and suppressive functions of Tregs under various experimental conditions that lead to Foxp3 generation by flow cytometry and ELISA respectively. Second, we studied the effect of MSCs on TRAF6, GRAIL, USP7, STUB1, and UBC13 mRNA expression in CD4+ T cells in correlation with the suppressive function of iTregs by real-time PCR; also, we investigated Foxp3 Treg-specific demethylated region (TSDR) methylation in correlation with Foxp3 stability by the high-resolution melting technique. Third, we studied the effect of ex-vivo-expanded BM-MSCs on the induction of transplant tolerance in a model of fully allogeneic skin transplantation. We further analyzed the cytokine secretion patterns in grafted mice as well as the mRNA expression of ubiquitination genes in CD4+ T cells collected from the spleens of protected mice. We found that in-vitro MSC-induced Tregs express high mRNA levels of ubiquitination genes such as TRAF6, GRAIL, and USP7 and low levels of STUB1. Moreover, they have enhanced TSDR demethylation. Infusion of MSCs in a murine model of allogeneic skin transplantation prolonged allograft survival. When CD4+ T cells were harvested from the spleens of grafted mice, we observed that mRNA expression of the Foxp3 gene was elevated. Furthermore, Foxp3 mRNA expression was associated with increased TRAF6, GRAIL, UBC13, and USP7 and decreased STUB1 mRNA levels compared with the levels observed in vitro. Our data suggest a possible ubiquitination mechanism by which MSCs convert Tconvs to suppressive and stable iTregs.
- 25 October 2018
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 9 (1) , 1-18
Open AccessInduction of CD4+CD25+FOXP3+ regulatory T cells by mesenchymal stem cells is associated with modulation of ubiquitination factors and TSDR demethylation
Mesenchymal stem cells (MSCs) are known for their ability to induce the conversion of conventional T cells (Tconvs) into induced regulatory T cells (iTregs) in specific inflammatory contexts. Stable Foxp3 expression plays a major role in the phenotypic and functional stability of iTregs. However, how MSCs induce stable Foxp3 expression remains unknown. We first investigated the role of cell–cell contact and cytokine secretion by bone marrow-derived MSCs (BM-MSCs) on the induction, stability, and suppressive functions of Tregs under various experimental conditions that lead to Foxp3 generation by flow cytometry and ELISA respectively. Second, we studied the effect of MSCs on TRAF6, GRAIL, USP7, STUB1, and UBC13 mRNA expression in CD4+ T cells in correlation with the suppressive function of iTregs by real-time PCR; also, we investigated Foxp3 Treg-specific demethylated region (TSDR) methylation in correlation with Foxp3 stability by the high-resolution melting technique. Third, we studied the effect of ex-vivo-expanded BM-MSCs on the induction of transplant tolerance in a model of fully allogeneic skin transplantation. We further analyzed the cytokine secretion patterns in grafted mice as well as the mRNA expression of ubiquitination genes in CD4+ T cells collected from the spleens of protected mice. We found that in-vitro MSC-induced Tregs express high mRNA levels of ubiquitination genes such as TRAF6, GRAIL, and USP7 and low levels of STUB1. Moreover, they have enhanced TSDR demethylation. Infusion of MSCs in a murine model of allogeneic skin transplantation prolonged allograft survival. When CD4+ T cells were harvested from the spleens of grafted mice, we observed that mRNA expression of the Foxp3 gene was elevated. Furthermore, Foxp3 mRNA expression was associated with increased TRAF6, GRAIL, UBC13, and USP7 and decreased STUB1 mRNA levels compared with the levels observed in vitro. Our data suggest a possible ubiquitination mechanism by which MSCs convert Tconvs to suppressive and stable iTregs.
- Open Access
- 1 January 2017
- Published by American Institute of Mathematical Sciences (AIMS) in AIMS Molecular Science
- Vol. 4 (1) , 103-109
Association of interleukin-2 gene variants (positions +114 and −384) and susceptibility to brucellosis in Iranian population
Brucella is an obligate intracellular gram negative bacterium and the causative agent of brucellosis. Interleukin-2 (IL-2) is a cytokine involved in cell-mediated immunity response secreted by activated T-cells and considered as the growth factor for T-cells. Previous reports have revealed that gene polymorphisms of cytokines can affect susceptibility to Brucella infection. The goal of this study was to investigate the relationship between IL-2 gene polymorphisms (positions +114 and −384) and susceptibility to brucellosis. A total of 173 brucellosis patients and 75 healthy animal husbandmen who had Brucella infected animals and consumed their contaminated dairy products, as control group, were included in this study. All participants were genotyped for IL-2 gene polymorphisms at positions +114 (G/T) and −384 (G/T), using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). The frequency of TT genotype at the position +114 was significantly higher in the controls, compared with the patients. But, there was no significant difference between the groups regarding TG and GG genotypes as well as T and G alleles. Furthermore, at position −384, the frequencies of G allele and GG genotype were higher in the controls compared with patients, however, they were not significantly different Additionally, TT/TT haplogenotype (+114/−384) was significantly higher in the controls, compared with the patients. Conclusively, it is suggested that the inheritance of TT genotype (position +114) and TT/TT haplogenotype (+114/−384) of IL-2 gene could be considered as one of the genetic factors responsible for resistance to brucellosis.
- 1 January 2017
- Published by American Institute of Mathematical Sciences (AIMS) in AIMS Molecular Science
- Vol. 4 (1) , 103-109
Open AccessAssociation of interleukin-2 gene variants (positions +114 and −384) and susceptibility to brucellosis in Iranian population
Brucella is an obligate intracellular gram negative bacterium and the causative agent of brucellosis. Interleukin-2 (IL-2) is a cytokine involved in cell-mediated immunity response secreted by activated T-cells and considered as the growth factor for T-cells. Previous reports have revealed that gene polymorphisms of cytokines can affect susceptibility to Brucella infection. The goal of this study was to investigate the relationship between IL-2 gene polymorphisms (positions +114 and −384) and susceptibility to brucellosis. A total of 173 brucellosis patients and 75 healthy animal husbandmen who had Brucella infected animals and consumed their contaminated dairy products, as control group, were included in this study. All participants were genotyped for IL-2 gene polymorphisms at positions +114 (G/T) and −384 (G/T), using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). The frequency of TT genotype at the position +114 was significantly higher in the controls, compared with the patients. But, there was no significant difference between the groups regarding TG and GG genotypes as well as T and G alleles. Furthermore, at position −384, the frequencies of G allele and GG genotype were higher in the controls compared with patients, however, they were not significantly different Additionally, TT/TT haplogenotype (+114/−384) was significantly higher in the controls, compared with the patients. Conclusively, it is suggested that the inheritance of TT genotype (position +114) and TT/TT haplogenotype (+114/−384) of IL-2 gene could be considered as one of the genetic factors responsible for resistance to brucellosis.
- 1 May 2014
- Published by CMV Verlag in Pars of Jahrom University of Medical Sciences
- Vol. 12 (2) , 57-63
Analysis of the presence of Epstein-Barr virus in Hodgkin's lymphoma in Iranian children by EBER in situ hybridization
- 1 May 2014
- Published by CMV Verlag in Pars of Jahrom University of Medical Sciences
- Vol. 12 (2) , 57-63
Analysis of the presence of Epstein-Barr virus in Hodgkin's lymphoma in Iranian children by EBER in situ hybridization
- 31 December 2009
- Published by Elsevier in Clinical Immunology
- Vol. 131, S131
F.138. Lack of Association Between Toll-like receptor 4 (TLR4 Asp299Gly, Thr399ILe, Ser400Asn) Polymorphisms and Susceptibility to Visceral Leishmaniasis
- 31 December 2009
- Published by Elsevier in Clinical Immunology
- Vol. 131, S131
F.138. Lack of Association Between Toll-like receptor 4 (TLR4 Asp299Gly, Thr399ILe, Ser400Asn) Polymorphisms and Susceptibility to Visceral Leishmaniasis
- 31 December 2009
- Published by Elsevier in Clinical Immunology
- Vol. 131, S103
F.35. Interleukin-15 Gene Polymorphisms (C267T, G367A, C13687A and A14035T) and Susceptibility to Brucellosis in Iranian Patients
- 31 December 2009
- Published by Elsevier in Clinical Immunology
- Vol. 131, S103
F.35. Interleukin-15 Gene Polymorphisms (C267T, G367A, C13687A and A14035T) and Susceptibility to Brucellosis in Iranian Patients
- 31 December 2009
- Published by Elsevier in Clinical Immunology
- Vol. 131, S97
F.13. Interleukin-18 Gene Polymorphisms are Associated with Brucellosis in Iranian Patients
- 31 December 2009
- Published by Elsevier in Clinical Immunology
- Vol. 131, S97
F.13. Interleukin-18 Gene Polymorphisms are Associated with Brucellosis in Iranian Patients